Go back to trials list
Evaluating the Impact of Targeted Physical Activity on Clinically Debilitated Dialysis Patients.
Description
This research is being done to better understand the impact of the use of a specific physical activity training program (GH Method) in dialysis/kidney disease patients.The 12-Month Randomized Trial Group will include a total of 150 patients from UI Health (≥ 18 years of age), who are on dialysis, or have chronic kidney disease stage 4 (CKD 4 = GFR between 15 and 29) or have chronic kidney disease stage 5 (CKD 5 = GFR below 15) and are considered clinically debilitated by their direct healthcare professional will be enrolled. Randomization will be a 2:1 ratio (100 intervention, 50 control). The intervention arm will perform a 12-month exercise intervention which involves two days a week of personalized exercise rehabilitation. The control arm will receive no exercise intervention. Both arms of patients will be tested on various measures of health and function both at baseline (prior to intervention) at 6 months, and at 12 months (post intervention). This study will also investigate the
Trial Eligibility
Inclusion Criteria: * Clinically debilitated patients, currently on dialysis, or have CKD 4 (GFR between 15 and 29), or have CKD 5 (GFR below 15), or post- kidney transplant (for PPKT Subgroup only) as stated by patient's health care professional. * Adequate cognitive ability to complete the questionnaires, give consent for the study and follow the physical and diet instructions Exclusion Criteria: * cardiac/pulmonary disease that contraindicate the physical training * Unable to give consent * Unable to travel to the training center
Study Info
Organization
University of Illinois at Chicago
Primary Outcome
Rate at which subjects will see changes in their physical abilities.
Interventions
Locations Recruiting
University of Illinois at Chicago
United States, Illinois, Chicago
Interested in joining this trial?
Our dedicated patient navigators are here to guide you through the validation and enrollment process with ease.
Get the latest thought leadership on your Kidney Disease delivered straight to your inbox
Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.